Evidence map›Paper›PMID 36926603›Full record

ArticleJournal of ginseng research2023

Corrigendum to "Ginsenoside Rb1 attenuates methamphetamine (METH)-induced neurotoxicity through the NR2B/ERK/CREB/BDNF signalings in vitro and in vivo models" [J Ginseng Res 46 (2022) 426-434].

Genmeng Yang, Juan Li, Yanxia Peng, Baoyu Shen, Yuanyuan Li, Liu Liu, Chan Wang, Yue Xu, Shucheng Lin, Shuwei Zhang and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of ginseng research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Genmeng YangNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, Yunnan Province, China.
Juan LiSchool of Basic Medicine, Kunming Medical University, Kunming, Yunnan Province, China.
Yanxia PengNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, Yunnan Province, China.
Baoyu ShenNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, Yunnan Province, China.
Yuanyuan LiNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, Yunnan Province, China.
Liu LiuNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, Yunnan Province, China.
Chan WangNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, Yunnan Province, China.
Yue XuNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, Yunnan Province, China.
Shucheng LinNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, Yunnan Province, China.
Shuwei ZhangNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, Yunnan Province, China.
Yi TanNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, Yunnan Province, China.
Huijie ZhangNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, Yunnan Province, China.
Xiaofeng ZengNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, Yunnan Province, China.
Qi LiSDIVF R&D Centre, Hong Kong, China.
Gang LuCUHK-SDU Joint Laboratory on Reproductive Genetics, School of Biomedical Sciences, the Chinese University of Hong Kong, Hong Kong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.jgr.2021.07.005.].

Identifiers

PMID36926603
PMCPMC10014215

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.